Protagenic Therapeutics (NASDAQ:PTIX) Shares Up 13.7%

Protagenic Therapeutics, Inc. (NASDAQ:PTIXGet Free Report)’s stock price shot up 13.7% during trading on Friday . The company traded as high as $0.85 and last traded at $0.85. 2,539 shares traded hands during trading, a decline of 80% from the average session volume of 12,413 shares. The stock had previously closed at $0.75.

Protagenic Therapeutics Stock Up 13.7 %

The stock has a fifty day simple moving average of $1.19 and a 200 day simple moving average of $1.15. The firm has a market capitalization of $3.80 million, a P/E ratio of -0.62 and a beta of 0.27.

Protagenic Therapeutics Company Profile

(Get Free Report)

Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses.

Recommended Stories

Receive News & Ratings for Protagenic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protagenic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.